Skip to content

Rodney J. Irvine

5 papers in the library · 117 citations · publishing 2001-2011

Papers

Sort Most recent Most cited

Pill content, dose and resulting plasma concentrations of 3,4‐methylendioxymethamphetamine (MDMA) in recreational ‘ecstasy’ users

Addiction February 14, 2011 Kate Morefield, Michael Keane, Peter Felgate et al. 83 citations

ABSTRACT Aims To improve our understanding of the pharmacology of ‘ecstasy’ in recreational environments; in particular, to describe the composition of ecstasy pills, patterns of ecstasy use and the relationship between dose of 3,4‐methylendioxymethamphetamine (MDMA) and resulting plasma concentrations. Design, setting and participants A naturalistic observational study of 56 experienced...

Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.

Neuropsychopharmacology February 2006 Annis O. Mechan, Jie Yuan, George Hatzidimitriou et al.

A large body of data indicates that (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') can damage brain serotonin neurons in animals. However, the relevance of these preclinical data to humans is uncertain, because doses and routes of administration used in animals have generally differed from those used by humans. Here, we examined the pharmacokinetic profile of MDMA in squirrel monkeys...

Effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide

Brain Research March 8, 2005 Alexander Freezer, Abdallah Salem, Rodney J. Irvine 34 citations

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and para-methoxyamphetamine (PMA) are commonly used recreational drugs. PMA, often mistaken for MDMA, is reported to be more toxic in human use than MDMA. Both of these drugs have been shown to facilitate the release and prevent the reuptake of 5-hydroxytryptamine (5-HT, serotonin). PMA is also a potent inhibitor of monoamine oxidase type A...

The health effects of ecstasy: a literature review.

Drug and Alcohol Review March 2002 Linda R Gowing, Susan M Henry-Edwards, Rodney J. Irvine et al.

Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is the third most used illicit drug, after cannabis and amphetamines. There has been considerable interest in the adverse effects of use, with particular attention given to a small number of deaths related to ecstasy use, and the neurotoxic effects of MDMA. This paper reviews case reports of adverse effects attributed to ecstasy use, and the...

The acute cardiovascular effects of 3,4‐methylenedioxymethamphetamine (MDMA) and p‐methoxyamphetamine (PMA)

Addiction Biology 2001 Rodney J. Irvine, Natasha P. Toop, Benjamin D. Phillis et al.

Abstract: A number of reports of severe acute toxicity as a result of recreational ingestion of what was believed to be 3,4‐methylenedioxymethamphetamine (MDMA) (ecstasy) have revealed, on chemical analysis of the victim's blood, to be due to p‐methoxyamphetamine (PMA). Increased blood pressure and heart rate have been associated with this toxicity, which is exacerbated by high ambient...